TIMP-2: an endogenous inhibitor of angiogenesis

William G Stetler-Stevenson1, Dong-Wan Seo

  • 1Cell & Cancer Biology Branch, Vascular Biology Faculty, CCR, NCI, NIH, Bldg. 10, Room 2A33, MSC# 1500, 10 Center Dr., Bethesda, MD 20892-1500, USA. sstevenw@mail.nih.gov

Insights

Tissue inhibitors of metalloproteinases (TIMPs) regulate matrix metalloproteinases (MMPs). TIMP-2 also has an MMP-independent function, acting as a cell-surface receptor to control cellular responses to growth factors.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • Extracellular matrix remodeling, regulated by matrix metalloproteinases (MMPs) and their inhibitors, is crucial in chronic diseases.
  • Uncontrolled MMP activity contributes to tissue damage, disease progression, and angiogenesis.
  • Tissue inhibitors of metalloproteinases (TIMPs) primarily regulate MMP activity.

Purpose of the Study:

  • To investigate the MMP-independent functions of TIMP-2.
  • To identify the mechanism by which TIMP-2 regulates cellular responses.
  • To propose a new model for TIMP-2's role in tissue homeostasis.

Main Methods:

  • Investigated the effect of TIMP-2 on human microvascular endothelial cells.
  • Assessed the mitogenic response of cells to growth factors in the presence of TIMP-2.
  • Identified a cell-surface signaling receptor for TIMP-2.

Main Results:

  • TIMP-2 demonstrated an MMP-independent inhibition of endothelial cell proliferation.
  • A novel cell-surface signaling receptor for TIMP-2 was identified.
  • TIMP-2 regulates cellular responses to growth factors through this receptor.

Conclusions:

  • TIMP-2 possesses functions beyond MMP inhibition.
  • TIMP-2 acts as a cell-surface receptor regulating cellular signaling.
  • This discovery offers a new perspective on TIMP-2's role in maintaining tissue homeostasis.